Intimation to Stock Exchanges

  • Notice of Board Meeting for Audited Financial Results and Dividend, if any
    11.05.2022
    Read More
  • Newspaper advertisement of extract of unaudited consolidated financial results for Q3
    15.02.2022
    Read More
  • Intimation of record date for Interim Dividend
    14.02.2022
    Read More
  • Declaration of Interim Dividend for FY 2021-22
    14.02.2022
    Read More
  • Notice of Board Meeting for Q3 results and Interim Dividend, if any
    07.02.2022
    Read More
  • Notice of Board Meeting for Q2 results
    30.10.2021
    Read More
  • Related Party Transactions for the half year ended September 30, 2021.
    30.09.2021
    Read More
  • Intimation of Record date
    11.08.2021
    Read More
  • Grant of Options under Employee Stock Option Scheme
    11.08.2021
    Read More
  • Related Party Transactions for the half year ended March 31, 2021
    09.07.2021
    Read More
  • Newspaper cutting of consolidated financial results for Q4 and year ended March 31, 2021
    15.06.2021
    Read More
  • Views of the Board of directiors on the reclassification request
    14.06.2021
    Read More
  • Recommendation of Final Dividend for FY. 2020-21
    14.06.2021
    Read More
  • Recommendation of Final Dividend
    08.06.2021
    Read More
  • Notice of Board Meeting
    04.06.2021
    Read More
  • Disclosure of receipt of requests from Promoters _ Promoter group memebrs seeking reclassification of status as public
    27.05.2021
    Read More
  • Secretarial Compliance Report 31.03.2021
    17.05.2021
    Read More
  • Launch of new dedicated division Renova to enter Nephrology segment in India
    06.05.2021
    Read More
  • Institution of new Employee Stock Option Scheme
    28.04.2021
    Read More
  • Outcome of Board meeting
    01.04.2021
    Read More
  • Notice of Board meeting
    25.03.2021
    Read More
  • Declaration of Interim dividend
    10.02.2021
    Read More
  • Board to consider decaration of Interim dividend
    05.02.2021
    Read More
  • Notice of Board for Q3 results
    28.01.2021
    Read More
  • Related Party transactions for the half year ended 30.09.2020
    26.11.2020
    Read More
  • Newspaper advertisement of extract of unaudited consolidated financial results for Q2
    11.11.2020
    Read More
  • Appointment of Chief Executive Officer _ Whole time Director
    05.10.2020
    Read More
  • Announcement of appointment of Mr.Nikhil Chopra as CEO _ Whole time director
    05.10.2020
    Read More
  • Board Meeting Norice for Q1 results
    05.09.2020
    Read More
  • Advertisement for dispatch of Letter of offer
    05.09.2020
    Read More
  • Resignation of Independent directors
    01.09.2020
    Read More
  • Detailed reasons for Encumbrance
    31.08.2020
    Read More
  • Change in Board of Directors
    31.08.2020
    Read More
  • Recommendation of IDC under SEBI SAST regulations
    27.08.2020
    Read More
  • Related party transctions for the half year eneded March 2020
    18.07.2020
    Read More
  • Letter of offer
    13.07.2020
    Read More
  • Notice of board meeting for annual financial results for the year ended March 31, 2020
    11.07.2020
    Read More
  • Board to consider recommedation of final dividend
    11.07.2020
    Read More
  • Recommendation of Final Dividend for FY 2019-20
    25.06.2020
    Read More
  • Secretarial Compliance Report -31.03.2020
    18.06.2020
    Read More
  • ANDA approval by USFDA
    27.04.2020
    Read More
  • News about Ranitidine formulations in the US
    02.04.2020
    Read More
  • Intimation of Record Date for interim dividend
    20.02.2020
    Read More
  • Declaration of Interim Dividend for FY 2019-20
    20.02.2020
    Read More
  • US FDA approval of new Solid Oral Dosage forms formulations manufacturing facility at Panoli, Gujarat
    11.02.2020
    Read More
  • Successful US FDA inspection of Solid Oral Dosage forms formulations manufacturing facility at Panoli, Gujarat
    10.02.2020
    Read More
  • Board to consider and declare interim dividend
    05.02.2020
    Read More
  • Acquistion of Trademarks
    04.02.2020
    Read More
  • Notice of board meeting for Q3 results
    06.01.2020
    Read More
  • J.B Chemicals clears the confusion about Rantac
    20.12.2019
    Read More
  • Regulatory one-time increase in price of Metronidazole formulations
    16.12.2019
    Read More
  • Related party transctions for the half year eneded September 2019
    20.11.2019
    Read More
  • Notice of board meeting for Q2 results
    04.10.2019
    Read More
  • Notice of board meeting for Q1 results
    19.07.2019
    Read More
  • Intimation of Record Date
    19.07.2019
    Read More
  • Related party transctions for the half year eneded March 2019
    06.06.2019
    Read More
  • Recommedation of dividend for FY 2018-19
    21.05.2019
    Read More
  • Board to consider recommedation of dividend
    08.05.2019
    Read More
  • Notice of board meeting for audited annual financial results for the year ended March 31, 2019
    05.04.2019
    Read More
  • Notice of Board Meeting for Q3 results
    10.01.2019
    Read More
  • Notice of Board Meeting for Q2 results
    16.10.2018
    Read More
  • channge in dividend payment date
    02.08.2018
    Read More
  • Notice of Board Meeting for Q1
    25.07.2018
    Read More
  • Board to consider recommendation of Dividend
    27.04.2018
    Read More
  • Notice of board meeting for Q3 results
    14.01.2018
    Read More
  • Notice of board meeting for Q2 results
    27.10.2017
    Read More
  • Change in dividend payment date
    27.08.2017
    Read More
  • Notice of board meeting for Q1 results
    27.07.2017
    Read More
  • Recommanadation of dividend for FY 2016-17
    23.05.2017
    Read More
  • Notice of board meeting for audited annual financial results for the year ended March 31, 2017
    04.05.2017
    Read More
  • Board to consider recommandation of Dividend for FY 2016-17
    04.05.2017
    Read More
  • Resignation of Director – Dr. Niranjan N. Maniar
    13.11.2016
    Read More
  • CSR Commitment
    13.10.2016
    Read More
  • Notice of board meeting for Q3 results
    04.10.2016
    Read More
  • Notice of board meeting for Q2 results
    04.10.2016
    Read More
  • Resignation of a director – Mr. Jashvantrai Joshi
    29.09.2016
    Read More
  • Intimation of record date _ book closure date for final dividend FY2015-16
    16.08.2016
    Read More
  • Notice of board meeting for Q1 results
    22.07.2016
    Read More
  • Notice of Board Meeting for audited annual fiancial results for the year ended March 31, 2016
    20.04.2016
    Read More
  • Resignation of a director – Mr. Mahesh K. Shroff
    11.03.2016
    Read More
  • Declaration of Interim Dividend for FY 2015-16
    11.03.2016
    Read More
  • Appointment of Indepenent Director-Mr. Shaukat Merchant
    16.02.2016
    Read More
  • Notice of Board Meeting for Q3 results
    06.01.2016
    Read More
  • Information under clause 36 of the Listing Agreement
    04.11.2015
    Read More
  • Notice of Board Meeting for Q2 results
    13.10.2015
    Read More
  • Intimation of change in dividend payment date
    07.09.2015
    Read More
  • Intimation of Book Closure
    07.09.2015
    Read More
  • Notice of Board Meeting for Q1 results
    22.07.2015
    Read More
  • Advance opportunity for registration of email-id
    31.05.2015
    Read More
  • Notice of Board Meeting for audited financial results for the year ended March 31, 2015
    07.05.2015
    Read More
  • Notice of board meeting for Q3 results
    31.12.2014
    Read More
  • Appointment of Director – Mr. Devang Shah
    17.12.2014
    Read More
  • Resignation of a director-Shri Bansidhar S. Mehta
    31.10.2014
    Read More
  • Notice of board meeting for Q2 results
    21.10.2014
    Read More
  • Notice of board meeting for Q1 results
    30.06.2014
    Read More
  • Recommendaton of dvidend for F.Y.2013-14
    26.05.2014
    Read More
  • Intimation to stock exchanges – Scheme of Amalgamation and Arrangement
    15.03.2014
    Read More